CD4+ T-cell activation by antigen-presenting cells infected with urease-deficient recombinant Mycobacterium bovis bacillus Calmette- Guérin

FEMS Immunology and Medical Microbiology

Volumn 53, Issue 1, 2008, Pages 96-106

  Mukai, Tetsu ^a   Maeda, Yumi ^a   Tamura, Toshiki ^a   Miyamoto, Yuji ^a   Makino, Masahiko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

BCG; Dendritic cell; Macrophage; Urease

Indexed keywords

BCG VACCINE; CD40 LIGAND; GAMMA INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UREASE;

ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; DENDRITIC CELL; DRUG SCREENING; MEMORY T LYMPHOCYTE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-1BETA; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MUTAGENESIS, INSERTIONAL; MYCOBACTERIUM BOVIS; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; UREASE;

EID: 43349090669     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2008.00407.x     Document Type: Article

References (33)

1. Andersen P Doherty TM (2005) The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3 : 656 662.
2. Bardarov S, Bardarov S Jr., Pavelka MS Jr., Sambandamurthy V, Larsen M, Tufariello J, Chan J, Hatfull G Jacobs WR Jr. (2002) Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148 : 3007 3017.
3. Charles C Shepard MD (1960) The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J Exp Med 112 : 445 454.
4. Clements DL, Lee BY Horwitz MA (1995) Purification, characterization, and genetic-analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol 177 : 5644 5652.
5. Dockrell HM, Young SK, Britton K et al 1996) Induction of Th1 cytokine responses by mycobacterial antigens in leprosy. Infect Immun 64 : 4385 4389.
6. Dye C, Watt CJ, Bleed DM, Hosseini SM Raviglione MC (2005) Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293 : 2767 2775.
7. Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP Steinman RM (2004) HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci USA 101 : 7669 7674.
8. Grode L, Seiler P, Baumann S et al 2005) Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J Clin Investig 115 : 2472 2479.
9. Hashimoto K, Maeda Y, Kimura H, Suzuki K, Masuda A, Matsuoka M Makino M (2002) Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect Immunity 70 : 5167 5176.
10. Honerzu Bentrup K Russell DG (2001) Mycobacterial persistence: adaptation to a changing environment [review]. Trends Microbiol 9 : 597 605.
11. Job CK (1989) Nerve damage in leprosy. Int J Lepr Other Mycobact Dis 57 : 532 539.
12. Kai M, Maeda Y, Maeda S, Fukutomi Y, Kobayashi K, Kashiwabara Y, Makino M, Abbasi MA, Khan MZ Shah PA (2004) Active surveillance of leprosy contacts in country with low prevalence rate. Int J Lepr Other Mycobact Dis 72 : 50 53.
13. Kaufmann SHE (2005) Introduction. Rational vaccine development against tuberculosis: "those who don't remember the past are condemned to repeat it". Microbes Infect 7 : 897 898.
14. Kaufmann SHE (2006) Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol 6 : 699 704.
15. Kaufmann SHE McMichael AJ (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11 : S33 S44.
16. Maeda S, Matsuoka M, Nakata N, Kai M, Maeda Y, Hashimoto K, Kimura H, Kobayashi K Kashiwabara Y (2001) Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother 45 : 3635 3639.
17. Maeda Y, Gidoh M, Ishii N, Mukai C Makino M (2003) Assessment of cell mediated immunogenicity of Mycobacterium leprae-derived antigens. Cell Immunol 222 : 69 77.
18. Makino M Baba M (1997) A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells. Scand J Immunol 45 : 618 622.
19. Makino M, Shimokubo S, Wakamatsu S, Izumo S Baba M (1999) The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J Virol 73 : 4575 4581.
20. Makino M, Maeda Y, Fukutomi Y Mukai T (2007) Contribution of GM-CSF on the enhancement of the T cell-stimulating activity of macrophages. Microbes Infect 9 : 70 77.
21. McDermott-Lancaster RD, Ito T, Kohsaka K, Guelpa-Lauras CC Grosset JH (1987) Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy. Int J Lepr Other Mycobact Dis 55 : 889 895.
22. Miyamoto Y, Mukai T, Takeshita F, Nakata N, Maeda Y, Kai M Makino M (2004) Aggregation of mycobacteria caused by disruption of fibronectin- attachment protein-encoding gene. FEMS Microbiol Lett 236 : 227 234.
23. Miyamoto Y, Mukai T, Nakata N, Maeda Y, Kai M, Naka T, Yano I Makino M (2006) Identification and characterization of the genes involved in glycosylation pathways of mycobacterial glycopeptidolipid biosynthesis. J Bacteriol 188 : 86 95.
24. Mochida-Nishimura K, Akagawa KS Rich EA (2001) Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocyte-macrophage colony-stimulating factor. Cell Immunol 214 : 81 88.
25. Orme IM, Roberts AD, Griffin JP Abrams JS (1993) Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 151 : 518 525.
26. Reyrat JM, Berthet FX Gicquel B (1995) The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guérin. Proc Natl Acad Sci USA 92 : 8768 8772.
27. Schaible UE, Sturgill-Koszycki S, Schlesinger PH Russell DG (1998) Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol 160 : 1290 1296.
28. Sendide K, Degmane AE, Reyrat JM, Talal A Hmama Z (2004) Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface. Infect Immun 72 : 4200 4209.
29. Setia MS, Steinmaus C, Ho CH Rutherford GW (2006) The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 6 : 162 170.
30. Stoner GL (1979) Importance of the neural predilection of Mycobacterium leprae in leprosy. Lancet 2 : 994 996.
31. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R Ottenhoff TH (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 101 : 4560 4565.
32. Wakamatsu S, Makino M, Tei C Baba M (1999) Monocyte-driven activation-induced apoptotic cell death of human T-lymphotropic virus type I-infected T cells. J Immunol 163 : 3914 3919.
33. World Health Organization 2006) Fact Sheet No. 104, Rev March